Twin Tree Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.32M Hold
15,300
0.03% 619
2025
Q4
$1.34M Sell
15,300
-20,800
-58% -$1.58M 0.01% 935
2025
Q3
$2.07M Buy
+36,100
New +$2.08M 0.01% 1034
2023
Q4
Sell
-5,000
Closed -$248K 1446
2023
Q3
$248K Sell
5,000
-25,100
-83% -$1.4M ﹤0.01% 1066
2023
Q2
$1.79M Sell
30,100
-8,000
-21% -$456K ﹤0.01% 943
2023
Q1
$2.16M Sell
38,100
-39,700
-51% -$2.55M ﹤0.01% 895
2022
Q4
$5.78M Sell
77,800
-16,600
-18% -$1.13M 0.01% 709
2022
Q3
$5.62M Buy
94,400
+64,100
+212% +$3.86M 0.01% 734
2022
Q2
$1.7M Buy
30,300
+16,900
+126% +$1.11M ﹤0.01% 1111
2022
Q1
$989K Buy
13,400
+12,300
+1,118% +$855K ﹤0.01% 1280
2021
Q4
$79K Buy
+1,100
New +$79.9K ﹤0.01% 1470

Other funds holding GMED

Twin Tree Management's GMED Position: Q2 2025 in Review

Twin Tree Management sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 3,017 shares — an estimated $221K sold.

Twin Tree Management first reported a position in GMED in Q3 2018 and held it in 13 quarters. The position peaked at $6.79M in Q2 2022. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

  • Twin Tree Management reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
  • Twin Tree Management sold 3,017 Globus Medical shares in Q2 2025, an estimated $221K.
  • Twin Tree Management first reported a position in Globus Medical in Q3 2018 and held it in 13 quarters.
  • Twin Tree Management's Globus Medical position peaked at $6.79M in Q2 2022.
  • 480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Twin Tree Management's 13F filing for Q2 2025, filed 28 Jul 2025.